Motor effects of typical and atypical antipsychotic drugs in rodents

Movement Disorders

Volumn , Issue , 2005, Pages 735-744

  Fowler, Stephen C ^a   McKerchar, T L ^a   Zarcone, T J ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247599916     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088382-0/50065-7     Document Type: Chapter

References (42)

1. Ahmed S., Chengapa K.N., Naidu V.R., Baker R.W., Parepally H., Schooler N.R. Clozapine withdrawal-emergent dystonias and dyskinesias: A case series. J Clin Psychiatry 1998, 59:472-477.
2. Bonuccelli U., Ceravolo R., Salvetti S., D'Avino C., Del Dotto P., Rossi G., Murri L. Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration. Neurology 1997, 49:1587-1590.
3. Brimblecombe R.W., Pinder R.M. Tremors and Tremorogenic Agents 1972, Scientechnica, Bristol, U. K.
4. Carlsson A., Lindqvist M., Magnusson T., Waldeck B. On the presence of 3-hydroxytyramine in brain. Science 1958, 127:471.
5. Casey D.E. Tardive dyskinesia: Pathophysiology. Psechopharmacology: The Fourth, Goneration of Progress 1995, 1497-1502. Kaven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
6. Ceravolo R., Salvetti S., Piccini P., Lucetti C., Gambaccvini G., Bonuccelli U. Acute and chronic effects of clozapine in essential tremol. Mov Disord 1999, 14:468-472.
7. Das S., Fowler S.C. Acute and subchronic effects of clozapine on licking in rats: Tolerance to disruptive effects on number of licks, but no tolerance to rhythm slowing. Psychopharmacology (Berlin, Ger.) 1995, 120:249-255.
8. Das S., Fowler S.C. Similarity of clozapine's and olanzapine's acute effects on rats' lapping behavior. Psychopharmacology (Berlin, Ger.) 1996, 123:374-378.
9. Delay J., Deniker P. Drug-induced extrapyramidal syndromes. Handbook of Clinical Neurology 1968, Vol. 6:248-266. North Holland, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
10. Ellenbroek B., Cools A.R. The paw test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. Life Sci 1988, 42:1205-1213.
11. Faustman W.O., Fowler S.C. An examination of methodological relinements, clozapine and fluphenazine in the anhedonia paradigm. Pharmacol Biochem Behav 1982, 17:987-993.
12. Fowler S.C., Das S. Haloperidol-induced decrements in force and duration of rats' tongue movements during licking are attenuated by concomitant anticholinergic treatment. Pharmacol Biochem Behav 1994, 49:813-817.
13. Fowler S.C., Mortell C. Low doses of haloperidol interfere with rat tongue extensions during licking: A quantitative analysis. Behav Neurosci 1992, 106:386-395.
14. Fowler S.C., Wang G. Chronic, haloperidol produces a time- and dose-related slowing of lick rhythm in rats: Implications for rodent models of tardive dyskinesia and neuroleptic-induced Parkinsonism. Psychopharmacology (Berlin, Ger.) 1998, 137:50-60.
15. Fowler S.C., Liao R.M., Skjoldager P. A new rodent model for neuroleptic-induced pseudo-Parkinsonism Low doses of haloperidol increase forelimb tremor in the rat. Behav Neurosci 1990, 104:449-456.
16. Fowler S.C., Davison K.H., Stanford J.A. Unlike haloperidol, clozapine slows and dampens rats' forelimb force oscillations and decreases force output in a press-while-licking behavioral task. Psychopharmacology (Berlin, Ger.) 1994, 116:19-25.
17. Hayes C.A. Differential effects of dopamine D1 (SCH23390) and D2 traclopride) antagonists, on quantitative characteristics of tongue movements in rats 1995, Unpublished Doctoral Dissertation, University of Mississippi, Oxford.
18. Hornykiewicz O. Neurochemistry of Parkinsonism. Handbook of Neurochemistry 1972, Vol. 7:465-501. Plenum Press, New York. A. Lajtha (Ed.).
19. Kaempf G.L., Porter J.H. Differential effects of pimozide and clozapine on schedule-controlled and scheduled-induced behaviors after acute and chronic administration. J Pharmacol Exp Ther 1987, 243:437-445.
20. Kallman M.J., Fowler S.C. Assessment of chemically induced alterations in motor functions. Principles of Neurotoxicology 1994, Vol. 26:373-396. Marcel Dekker, New York. L.W. Chang (Ed.).
21. Llinas R., Volkind R.A. The olivo-cerebellar system: Functional properties as revealed by harmaline-induced tremor. Exp Brain Res 1973, 18:69-87.
22. Moore N.A., Tye N.C., Axton M.S., Risius F.C. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 1992, 262:545-551.
23. Pisa M., Schranz J.A. Dissociable motor roles of the rat's, striatum conform to a somatotopic model. Behav Neurosci 1988, 102:429-440.
24. Remington G. Understanding antipsychotic "atypicality": A clinical and pharmacological moving target. J Psychiatry Neurosci 2003, 28:275-284.
25. Salamone J.D., Zigmond M.J., Stricker E.M. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience (Oxford, U. K.) 1990, 39:17-24.
26. Sanberg P.R., Bunsey M.D., Giordano M., Norman A.B. The catalepsy test: Its ups and downs. Behav Neurosci 1988, 102:748-759.
27. Sanger D.J. The effects of clozapine on shuttle-box avoidance responding in rats: Comparisons with haloperidol and chlordiazepoxide. Pharmacol Biochem Behav 1985, 23:231-236.
28. Stanford J.A., Fowler S.C. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: Evidence for a cholinergic mechanism. Neurosci Lett 1997, 225:157-160.
29. Stanford J.A., Fowler S.C. Subchronic effects of clozapine and haloperidol on rats' forelimb force and duration during a press-while-licking task. Psychopharmacology (Berlin, Ger.) 1997, 130:249-253.
30. Stanford J.A., Fowler S.C. Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness. Psychopharmacology (Berlin, Ger.) 1997, 132:408-414.
31. Stanford J.A., Fowler S.C. Clozapine-like motor effects of the atypical antipsychotic risperidone in rats. Neurosci Lett 2000, 285:189-192.
32. Stille G., Lauener H., Eichenberger E. The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(b,e)(1,4)diazepine (clozapine). Farmacol [Prat] 1971, 26:603-625.
33. Tarsy D. Neuroleptic-induced movement disorders. Disorders of Movement: Clinical, Pharmacological and Physiological Aspects 1989, 361-393. Academic Press, San Diego. N.P. Quinn, P.G. Jenner (Eds.).
34. Tarsy D., Baldessarini R.J., Tarazi F.I. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 2002, 16:23-45.
35. Tollefson G.D., Dellva M.A., Mattler C.A., Kane J.M., Wirshing D.A., Kinon B.J. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The collaborative crossover study group. J Clin Psychopharmacol 1999, 19:435-443.
36. Varvel S.A., Vann R.E., Wise L.E., Philibin S.D., Porter J.H. Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology (Berlin, Ger.) 2002, 160:182-191.
37. Vrtunski P.B., Konicki P.E., Kwon K.Y., Jurjus G., Jaskiw G.E., Jaskiw G.J. Effect of clozapine on motor function in schizophrenic patients. Schizophr Res 1996, 20:187-198.
38. Vrtunski P.B., Konicki P.E., Jaskiw G.E., Brescan D.W., Kwon K.Y., Jurjus G. Clozapine effects on force control in schizophrenic patients. Schizophr Res. 1998, 34:39-48.
39. Wang G., Fowler S.C. Effects of haloperidol and clozapine on tongue dynamics during licking in CD-1, BALB/c and C57BL/6 mice. Psychopharmacology (Berlin, Ger.) 1999, 147:38-45.
40. Wang G. Quantification of harmaline or physostigmine's tremorogenic effects and clozapine's antitremor effect 2000, Unpublished Doctoral Dissertation, University of Kansas.
41. Whishaw I.Q., Funk D.R., Hawryluk S.J., Karbashewski E.D. Absence of sparing of spatial, navigation, skilled forelimb and tongue use and limb posture in the rat after neonatal dopamine depletion. Physiol Behav 1987, 40:247-253.
42. Wiley J.L., Compton A.D., Porter J.H. Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. Pharmacol Biochem Behav 1994, 48:253-257.